06/15/2026
A vaccine designed by colleagues at Los Alamos National Laboratory and University of Oxford, targets conserved regions of —those less prone to mutation—making it effective across diverse populations and viral strains of HIV. Our investigators led a new study to determine the effectiveness of the vaccine to boost CD8 , to help the body destroy HIV-infected cells. The results are advancing our understanding of HIV immunology while offering hope that these vaccines could contribute to novel, curative approaches against HIV.
UNC Department of Medicine UNC Health UNC School of Medicine NC Health News
T-cells are the immune system’s frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial published in the Journal of Clinical Investigation, researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID) at the UNC School of Medicine have demo...